NewsRoom Articles - Page 198 of 214

MondaySep 21, 2020 11:00 am

Important Coronavirus Pandemic Lessons for the Diagnostics Industry

As we all know by now, the best way to help stop the spread of coronavirus is getting a coronavirus test done and wearing a mask, of course. A test reveals whether a person is negative or positive. A negative test result means an individual does not have the virus while a positive result means that one does have the virus. As we have seen, a positive rest result warrants quarantine for a 2-week period during which an individual is observed or treated, depending on the severity of their symptoms. Around the world, 200 million tests have been performed. However,…

FridaySep 18, 2020 12:45 pm

How Genetics Influence Episodic and Chronic Migraines

According to statistics, migraines are a common ailment as about 15% of the world’s population suffer from them at least once in their lives or frequently. In Russia, the rate is at 20%. Currently, the diagnosis and treatment methods of migraines are based on a patient’s grievances. The Gene and Cell Technologies Lab and the KFU Neurobiology Lab conducted this research. For a period of 2 years, the team studied individuals for genetic markers of migraines. Their colleagues from the Kazan State Medical University and Saint Petersburg also contributed to this research study. Aliya Yakubova, a Neurologist and junior research…

FridaySep 18, 2020 9:00 am

4 Face Mask Myths

The Centers for Disease Control and Prevention (“CDC”) recently stated that “Cloth face coverings are one of the most powerful weapons we have to slow and stop the spread of the virus,” (https://ibn.fm/1yiUN). However, there are people that believe alternative sources, or unsubstantiated myths, such as those listed below. Wearing a mask causes carbon dioxide build-up, especially when worn for a long period of time Some people claim they won’t be able to breathe if they have a mask on. However, there is no scientific truth behind this claim. Take for instance, health care workers, who wear masks for many…

ThursdaySep 17, 2020 2:45 pm

Researchers Study Whether Soy Could Improve the Treatment of Bone Cancer

In recent years, researchers have demonstrated the various health benefits that soy possesses. Some have linked the consumption of soy to reduced cancer, obesity as well as improved bone health. Now researchers from WSU are planning to utilize the benefits of soy to help better postoperative bone cancer treatment. In the Acta Biomaterialia journal, Naboneeta Sarkar, a graduate student and Susmita Bose, professor from the school of Mechanical and Materials Engineering, WSU, demonstrated that the steady release of chemical compounds that are soy-based from a bone-structure that was 3D printed led to the decrease of osteosarcoma cells as well as…

ThursdaySep 17, 2020 11:45 am

AI Helps Scientists Examine Gene Activation

Scientists from UC, San Diego have finally worked out an enigma in human gene activation. As illustrated in the journal Nature, this discovery may be used to control gene activation in biomedical and biotechnology applications. For a long time, scientists have known that the human genes act using instructions that are delivered by the specific order of a human’s DNA. This is directed by the 4 types of individual links, coded C, A, T and G. About 25% of a human’s genes are transcribed in sequences resembling TATAAA, which is referred to as the TATA box. However, for the remaining…

ThursdaySep 17, 2020 11:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Sub-Licensee Partner Announces CRO for Phase 1 and Phase 2 Berubicin Trials in Poland

Poland trials will include the first ever Phase 1 trial for pediatric patients suffering from glioblastoma multiforme CNS Pharmaceuticals has made significant strides in its Berubicin manufacturing process due to its dual-track approach and expects to begin production of its drug candidate at Pharmaceuticals International during the third quarter of 2020 The Company’s CFO recently acquired 142,000 shares of common stock in the open market, a move indicative of his confidence in the success of Berubicin clinical trials and its positive impact on the global brain tumor therapeutics market CNS Pharmaceuticals (NASDAQ: CNSP) is moving forward with clinical trials of…

WednesdaySep 16, 2020 3:30 pm

NIH Ramps Up National Covid-19 Testing Capacity

The National Institutes of Health (“NIH”) recently announced that they had allocated $129.3 million for upscaling and manufacturing new coronavirus testing technology. This would be part of its Rapid Acceleration Diagnostics initiative (RADx). The National Institutes of Health will be awarding the contracts to 9 firms for technologies which include high-throughput labs that can produce results in 24 hours and portable point-of-care tests for immediate results. Francis S. Collins, the NIH director, stated that diagnostic testing was an essential part of the country’s strategy to deal with the coronavirus pandemic. The RADx initiative, which began at the end of April…

WednesdaySep 16, 2020 11:15 am

Options for Individuals with Cancer-Causing Gene Mutations

Genetic testing and counseling services may help in determining if a person has the BRCA1 and BRCA2 gene mutations. Some people may have an inherited mutation in either one or both of these genes that increases their risk of breast cancer. These mutations can be passed to an individual from either of their parents and can affect both men and women. If it turns out that you carry these mutations, then below are some of the options that you have that might help inform you on treatment alternatives as well as cancer prevention. The best person to discuss possible options…

WednesdaySep 16, 2020 11:06 am

Predictive Oncology Inc. (NASDAQ: POAI) Confirms Attendance at Upcoming LD 500 Microcap Investor Conference

Predictive Oncology presenting at upcoming LD 500 investor conference Investor event will take place Sept. 1-4, 2020 and will feature 500 handpicked companies from across North American listed micro-cap universe Predictive Oncology specializes in applying data and artificial intelligence to cancer personalized medicine, drug discovery Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, has announced that it will be presenting at the upcoming LD 500, an investor conference set to take place in an entirely virtual setting Sept. 1-4, 2020 (http://ibn.fm/42UBB). With 500 handpicked companies…

WednesdaySep 16, 2020 10:30 am

180 Life Sciences Corp. Pursuing Novel Solutions to Inflammatory Illnesses as Merger Nears Completion

180 Life Sciences is a clinical-stage biotechnology company that is developing therapies to combat inflammation in patients with chronic inflammation-related illnesses The company is being acquired by special purpose acquisition corporation KBL Merger Corp. IV (NASDAQ: KBLM) and will be listed on the Nasdaq Capital Market under ticker symbol ATNF when the deal closes later this year Analysts forecast the anti-inflammatory therapeutics market will be worth $191.42 billion by 2027, growing at a CAGR of 3 percent 180 Life Sciences is completing phase 2b/3 clinical trials tackling fibrosis and inflammation-causing TNF substance aberrations The sudden and surprise impact of the…